Description: Hydroxychloroquine Sulfate Tablets USP 200 mg exporters, Hydroxychloroquine Sulfate Tablets USP 200 mg wholesalers, Hydroxychloroquine Sulfate Tablets USP 200 mg companies listings, Hydroxychloroquine Sulfate Tablets USP 200 mg catalogs, Hydroxychloroquine Sulfate Tablets USP 200 mg india, Hydroxychloroquine Sulfate Tablets USP 200 mg Manufacturers and Exporters. Hydroxychloroquine Sulphate Tablets 200mg Technical Specification: Product Name:Hydroxychloroquine Sulphate Tablets 200mg Brand Name:Generics Strength:200mg Dosage Form:Tablet (Film-coated) Route of Administration:Via oral Route Packing:10s, 30s, 100s Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) Regulatory Documents:COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier Therapeutic use: Antimalarial, Anti-inflammatory, AntiCovid, Covid, Coronavirus Indication:Hydroxychloroquine is used to treat discoid lupus erythematosus (DLE) or systemic lupus erythematosus (SLE or lupus). It is also used to treat acute and chronic rheumatoid arthritis. This medicine is available only with your doctor’s prescription. Storage:Protect form moisture at a temperature not exceeding 30˚C.Do not freeze. Keep the container tightly closed in order to protect from moisture. Hydroxychloroquine Sulfate Tablets 200mg Manufacturers, Suppliers in India Taj Pharmaceuticals is of the prominent Hydroxychloroquine Sulfate Tablets 200 mg Manufacturers India brings the best- quality products. Out company Taj Pharma carries the rich experience in the niche manufacturing of Hydroxychloroquine Tablets. Taj Pharmaceuticals is reputed manufacturer and Hydroxychloroquine Tablets 200 mg Suppliers in India prefer Taj Pharma is best known for the top most standards and consistent quality of products. Taj Pharma is well-known Hydroxy-chloroquine Tablets USP 200 mg Manufacturer in India gives the assurance of high- quality and high standard. The strict quality-control ensure that every batch of the medicine brings a harmonious standard. Hydroxy-chloroquine Tablets USP 200 mg manufactured at Taj Pharma follows USP (United States Pharmacopeia); i.e. the product is manufactured to comply USP quality standards which is considered best in the world. Further, Taj Pharma uses Hydroxychloroquine Sulfate USP grade best active ingredient to manufacture its tablets to comply with international standards of USA and European products. Hydroxychloroquine Sulfate Tablets 200mg Manufacturers, Suppliers in India: Taj Pharmaceuticals is of the prominent Hydroxychloroquine Sulfate Tablets 200 mg Manufacturers India brings the best- quality products. Out company Taj Pharma carries the rich experience in the niche manufacturing of Hydroxychloroquine Tablets. Taj Pharmaceuticals is reputed manufacturer and Hydroxychloroquine Tablets 200 mg Suppliers in India prefer Taj Pharma is best known for the top most standards and consistent quality of products. Taj Pharma is well-known Hydroxy-chloroquine Tablets USP 200 mg Manufacturer in India gives the assurance of high- quality and high standard. The strict quality-control ensure that every batch of the medicine brings a harmonious standard. Hydroxy-chloroquine Tablets USP 200 mg manufactured at Taj Pharma follows USP (United States Pharmacopeia); i.e. the product is manufactured to comply USP quality standards which is considered best in the world. Further, Taj Pharma uses Hydroxychloroquine Sulfate USP grade best active ingredient to manufacture its tablets to comply with international standards of USA and European products. As Hydroxychloroquine Tablets 200 mg Exporters; We can cater to export business queries from the following geographies. We are exporting our Hydroxychloroquine Tablets 200 mg product in Following Countries- Russia and CIS Countries: Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Uzbekistan and Ukraine GCC/ Middle East Countries: Saudi Arabia, Yemen, Oman, Bahrain, UAE, Lebanon, Jordan, Iraq. African Countries: Nigeria, Tanzania, Sudan, Zambia, Benin, Angola, Liberia Southeast Asia: Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, Brunei Darussalam Other Asian Countries: Nepal, Myanmar, Malaysia, Cambodia, Bhutan, Sri Lanka, Mauritius Hydroxychloroquine Tablets 200mg Regulatory Documents: Certificate of Analysis (COA) Method of Analysis (MOA) Stability Data (Accelerated stability / Long term stability / Zone 4b) CTD Dossier / ACTD Dossiers / eCTD Dossiers Certificate of Pharmaceuticals Product (COPP) Free Sale Certificate (FSC) Hydroxy-chloroquine 200mg Tablets as prophylaxis for SAR- covid-19 Hydroxy-chloroquine Sulfate tablets 200mg is found to be effective against covid in laboratory studies and in-vivo studies. Its use in prophylaxis is derived from arcinale evidence of benefias treatment and supported by pre-clinical data. As Hydroxychloroquine Tablets 200 mg Exporters; We can cater to export business queries from the following geographies. We are exporting our Hydroxychloroquine Tablets 200 mg product in Following Countries- Russia and CIS Countries: Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Uzbekistan and Ukraine GCC/ Middle East Countries: Saudi Arabia, Yemen, Oman, Bahrain, UAE, Lebanon, Jordan, Iraq. African Countries: Nigeria, Tanzania, Sudan, Zambia, Benin, Angola, Liberia Southeast Asia: Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, Brunei Darussalam Other Asian Countries: Nepal, Myanmar, Malaysia, Cambodia, Bhutan, Sri Lanka, Mauritius Hydroxychloroquine Tablets 200mg Regulatory Documents: Certificate of Analysis (COA) Method of Analysis (MOA) Stability Data (Accelerated stability / Long term stability / Zone 4b) CTD Dossier / ACTD Dossiers / eCTD Dossiers Certificate of Pharmaceuticals Product (COPP) Free Sale Certificate (FSC) Hydroxy-chloroquine 200mg Tablets as prophylaxis for SAR- covid-19 Hydroxy-chloroquine Sulfate tablets 200mg is found to be effective against covid in laboratory studies and in-vivo studies. Its use in prophylaxis is derived from arcinale evidence of benefias treatment and supported by pre-clinical data.
Dimensions: 2560 x 1707
File Type: jpeg
File Size: 224 KB
